Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Choosing between cash back and points for travel can impact your rewards. Explore which option suits your travel style!
27,012 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
As bitcoin oscillates, MSTY investors confront a structural risk tied to the ETF’s option strategy. The fund’s income...
As SECURE 2.0 is fully in effect, a $1.5 million 401(K) can leverage a Qualified Longevity Annuity Contract to lower ...
Pension funds are quietly pouring billions into a Treasury ETF on a quarterly cadence, a trend reshaping fixed-income...
Investors chasing steady monthly payouts in JEPQ face a trade-off: higher income amid lower long-run gains versus bro...
A Friday Supreme Court ruling spurs new tariffs, forcing small business owners scramble to cope as costs rise and cas...
Anthropic's Mythos stirred AI headlines and sent one cybersecurity stock soaring. This article breaks down whether PA...
Mining profitability remains under pressure as hashprice tests new lows for 2026. Analysts say the bitcoin miner bott...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
In a market of rising debt and high home prices, Dave Ramsey’s debt-paydown principles and focus on modest living are...
A retired couple confronts a tax cliff as their home equity climbs. They choose to stay, prioritizing a stepped-up ba...